Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

146.69 +1.41 (+0.97%)
Streaming Delayed Price Updated: 11:15 AM EDT, May 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Johnson & Johnson

< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
95 96 Next >
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for... 
Via Benzinga
Exposures Product Safety
Johnson & Johnson Unusual Options Activity
Via Benzinga
AstraZeneca's Tagrisso-Chemo Combo Data In Lung Cancer Sets High Bar For Johnson & Johnson's Cancer Drug: Analyst
On Sunday night, AstraZeneca Plc (NASDAQ: AZN) presented the Phase 3 FLAURA2 results evaluating Tagrisso plus chemotherapy versus Tagrisso monotherapy as first-line treatment for patients  
Via Benzinga
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
The convergence of artificial intelligence (AI) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug discovery to patient care.... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Could This Issue Sink Johnson & Johnson's Stock Price?
Don't be too quick to press the sell button. 
Via The Motley Fool
Analyst Ratings for Johnson & Johnson
Via Benzinga
(JNJ) - Analyzing Johnson & Johnson's Short Interest
Via Benzinga
Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis
Sandoz, a generic and biosimilar medicines unit of Novartis AG (NYSE: NVS), has  
Via Benzinga
3 Bulletproof Stocks to Buy Before the Next Recession Strikes
With these three bulletproof stocks, investors seek refuge in stable and growth-oriented stocks as the specter of economic downturns looms. 
Via InvestorPlace
Topics Economy
Exposures Economy
Warren Buffett's Highest-Yielding Stock Isn't Citigroup at 5%. He's Netting Almost 57% Annually From Another Top Holding.
Relative to Berkshire's cost basis in the company, this longtime Buffett holding is generating more than 11 times the nominal yield of Citigroup. 
Via The Motley Fool
The 7 Best Warren Buffett Stocks to Buy Now: September 2023
With investors not sure of their next move, trying your luck with the best Warren Buffett stocks could be a confidence booster. 
Via InvestorPlace
New to Investing? Here's How You Can Get Started With $500.
You don't have to invest a lot to start building a winning portfolio. 
Via The Motley Fool
Is J&J a Buy After the Kenvue Separation?
J&J shares have been on the decline. 
Via The Motley Fool
Check Out What Whales Are Doing With JNJ
Via Benzinga
3 No-Brainer Dividend Stocks to Buy No Matter What the Market Is Doing
You'll want to hold on to these players for the long term. 
Via The Motley Fool
The 5 Best Healthcare Stocks to Buy Now: September 2023
Unearth the best healthcare stocks offering attractive entry points and opportunities for significant returns. Start investing today! 
Via InvestorPlace
September Rally? 3 Healthcare Stocks to Buy Before Liftoff.
The anticipated volume of future healthcare spending makes this a time to look at healthcare stocks to buy for the long term. 
Via InvestorPlace
3 Shaky Stocks to Sell in September Before It’s Too Late
Here's a list of stocks to sell that can put your portfolio at potential risk of losses due to legal exposure or poor performance. 
Via InvestorPlace
The 7 Best Dow Stocks to Buy Now: September 2023
These are the best Dow stocks to buy because they offer long-term growth, a margin of safety and reliability in an otherwise volatile market. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
1 Brand-New Dividend Stock Income Investors Won't Want to Miss
The recently spun-off Kenvue looks to be a high-quality dividend stock. 
Via The Motley Fool
7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth
Finding the best pharma stocks to buy takes a little effort, but it will pay of with these seven long-term winners. 
Via InvestorPlace
The 25 Best Stocks By Shareholder Wealth Creation (1926-2022)
Via Talk Markets
Johnson & Johnson Cancer Drug Rybrevant Shows Improvement In Broader Lung Cancer Population
Janssen, a unit of Johnson & Johnson (NYSE: JNJ),  
Via Benzinga
Why Is Infectious Diseases Focused Cidara Therapeutics Stock Trading Higher Today?
Cidara Therapeutics Inc (NASDAQ: CDTX) shares are trading higher after the company announced that Janssen Pharmaceuticals Inc, a unit of Johnson & Johnson (NYSE: JNJ), decided to pr 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
Via Benzinga
7 Retirement Stocks That Every Long-Term Investor Should Own Now
Boost your investment portfolio with these seven top long-term retirement stocks to buy and hold for this decade. 
Via InvestorPlace
Topics Retirement
Exposures Pension
Facebook News To Shut Down In Europe, Warner Bros. Discovery Revises Outlook As Strike Bites, Manchester United No Longer Up For Sale: Today's Top Stories
Benzinga Why Facebook News is Shutting Down in Europe: What It Means for Users? 
Via Benzinga
Johnson & Johnson's Growth Strategy Post Tylenol Parent Kenvue Split: Paving the Way for Medical Innovation
Johnson & Johnson (NYSE: JNJ) is gearing up to use the proceeds from the recent separation of its consumer-health segment Kenvue Inc (NYSE: KVUE) to bolster its growth in  
Via Benzinga
Legal Twist In Drug Price Negotiation: Federal Judge Quits Case Amid Allegations Of Stock Ownership
On Friday, Judge Thomas Rose, serving in the U.S. 
Via Benzinga
3 Dow Stocks to Sell in September Before They Crash and Burn
Despite the Dow's reputation of consisting of only solid, blue-chip stocks, these three are proving risky and making the list of Dow stocks to sell. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
95 96 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.